Cancer Research UK and partners announce new global phase 2 trial in rare adrenal gland cancer
Cancer Research UK, Cytovation and the Norwegian Cancer Society have announced a new multi-national Phase 2 clinical trial (CLARITY; ISRCTN15479264) for people with advanced adrenocortical carcinoma (ACC), a rare and […]
World leading research receives cash boost in Manchester
Cancer Research UK will invest an additional £6m each year into world-leading research in Manchester and create up to an additional 100 new jobs. The charity’s annual investment into the Cancer Research […]
Hundreds of cancer patients to benefit from improved access to genetic testing
Cancer Research UK has announced that from now it is making hundreds of specialised blood tests available to people affected by cancer across the UK. As a co-funder of the […]
UCB, Cancer Research UK and Cancer Research Horizons announce new strategic alliance to accelerate development of novel cancer therapies
UCB, a global biopharmaceutical company, has announced a new multi‑project strategic alliance with Cancer Research UK and its innovation arm, Cancer Research Horizons. The collaboration will unite Cancer Research UK’s […]
New £1m clinical trial launches to improve quality of life for people with blood cancer
Dr Kevin Rouault-Pierre and team at Barts Cancer Institute, Queen Mary University of London, have been awarded funding to launch a new clinical trial aiming to improve quality of life […]
First-of-its-kind international trial launches to harness the immune system against childhood cancers
The first person has been enrolled in a new clinical trial taking place in the UK and the US, offering a specific group of up to 60 children with cancer […]
Research paper shows screening for lung cancer dramatically increases early-stage detection, helping to save lives
A new research paper in Nature Medicine shows screening for lung cancer dramatically increases early-stage detection, particularly in socioeconomically deprived areas, helping to save lives. Between April 2019 and March […]
Cancer Research UK and NovalGen dose the first patient in the phase 1 trial of T-cell engager NVG-222
Cancer Research UK’s Centre for Drug Development (CDD) and NovalGen yesterday announced that the first patient has been dosed in a Phase 1 clinical trial evaluating NVG‑222, NovalGen’s next-generation self‑regulating […]
Five global teams awarded £100 million to take on the toughest challenges at the frontiers of cancer science
Cancer Grand Challenges, a global initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, has announced a major £100m commitment to propel cancer research into […]
Cancer Research Horizons makes one of the largest oesophageal cancer datasets available for commercial licensing
Cancer Research Horizons, the innovation engine of Cancer Research UK, is proud to announce the addition of the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study dataset to its growing […]
